Topic · 2 reports

FTC Enforcement

RegulationWatch reporting on ftc enforcement matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. FTC Enforcement

    FTC pauses OptumRx insulin case to weigh proposed consent agreement

    The Federal Trade Commission withdrew its insulin pricing case against UnitedHealth's OptumRx and its affiliate Emisar from adjudication to consider a proposed consent agreement. The agreement has been approved by the directors of the FTC's competition and consumer protection bureaus but still requires Commission approval, and its terms have not been disclosed.

  2. FTC Enforcement

    FTC settles insulin rebate case with Cigna's Express Scripts under sweeping consent order

    The Federal Trade Commission settled its insulin rebating case against Express Scripts, the Cigna-owned pharmacy benefit manager. The consent order requires formulary, compensation and transparency changes that the FTC estimates will save patients up to $7 billion in out-of-pocket costs over ten years.